Inhalational Anesthesia Market Size, Share & Industry Analysis, By Product (Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide), By Application (Induction, Maintenance), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) And Regional Forecast, 2026-2034

The global inhalational anesthesia market size was valued at USD 1.64 billion in 2025. The market is projected to grow from USD 1.75 billion in 2026 to USD 2.95 billion by 2034, exhibiting a CAGR of 6.75% during the forecast period.

During surgical procedures, anesthetic agents are used to control blood pressure, heart rate, pain, blood flow, and breathing. Inhalational anaesthetics are used as induction and maintenance of general anesthesia along with sedation in patients. The inhalational anaesthetics are mostly preferred for maintenance purpose as it allow more precise control of the anaesthetic state comparatively at a lower cost.

Inhalation anaesthetics are mostly used during accident care, as in an ambulatory setting, it is not easy to choose intravenous route of administration. Rapid sequence induction of general anesthesia during emergency labor procedures is performed with the intubation of the trachea. Inhalation anesthesia enables the occurrence of immobility and amnesia, except for nitrous oxide, which creates an analgesic effect. Some of the adverse reactions of inhalation anesthesia includes nausea. It is produced by the respiration of the volatile liquid, gaseous anaesthetic agent.

The global inhalation anesthesia market is expected to grow significantly because of the rise in the number of surgeries globally, increasing number of medical procedures, and the rise in geriatric population as they are more prone to develop various health disorders. These factors that are expected to help the market grow in the forecast period.

However, the environmental issues associated with the emission of anesthetic gases along with the side effects associated with inhalational anesthetics may result in lower adoption rates, which may restrain the market growth.

Key Market Driver -

Rise in the demand for surgical procedures will lead to increase in demand for these products, favoring the market growth.

Key Market Restraint -

Side effects associated with inhalation anesthetics and the lower adoption rate during surgical procedures are restraining the growth of the market

Market Segmentation:

Globally, the inhalational anaesthetics market can be segmented on the basis of product, application, distribution channel, and region. Based on product, the market can be segmented into sevoflurane, desflurane, isoflurane and nitrous oxide. Based on application, the market can be segmented into induction and maintenance. Based on distribution channel, the market can be segmented into hospitals pharmacies, drug stores & retail pharmacies, and online pharmacies. Geographically, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

Key Players Covered:

The major companies in the global inhalational anesthesia market report includes Fresenius Kabi AG, Abbott, Baxter, Halocarbon Products, Jiangsu Hengrui Medicine, Hikma Pharmaceuticals, Piramal Enterprises Limited, AbbVie Inc., Viatris Inc., Lunan Pharmaceutical Group, Eisai Co., Ltd., and other prominent companies.

Key Insights

• Impact of COVID-19 on the Global Inhalational Anesthesia Market
• Key Industry Developments
• Number of Surgical Procedures - By Key Countries/Regions
• Technological advancements in Inhalational Anesthesia Market

Regional Analysis:

North America is expected to grow at a lucrative rate over the forecast period, owing to the increasing prevalence of various chronic diseases and the presence of advanced healthcare facilities. Increase in demand for surgical procedures such as inpatient surgery as well as ambulatory surgery in North America, is a major growth driver for the region. The Europe market is anticipated to witness a significant growth due to increasing number of surgeries along with prevalence of various chronic diseases.

The Asia Pacific region is expected to expand over the forecast period. The factors responsible for the rapid growth include increase in population, increasing availability of healthcare insurance for masses, rising public and private healthcare expenditure, and the incidence of chronic diseases. Rise in surgical procedures in the Latin America and the Middle East and Africa markets are expected to create new opportunities for the growth of these regions in the forecast period.

To gain extensive insights into the market, Download for Customization

Segmentation

Inhalational Anesthesia Industry Developments

• In July 2020, Baxter International Inc. announced that they have entered into an agreement with ZeoSys Medical to commercialise the technology to capture and recycle the anaesthetics gases. The agreement helps Baxter with the global distribution rights to commercialize the technology outside Europe.